Daily Market Updates: Novo Nordisk signs second licensing deal after investors reacted coolly

ETFs & Funds

Home›ETFs & Funds›Fund Industry›Novo Nordisk signs second licensing deal after investo…

Novo Nordisk signs second licensing deal after investors reacted coolly

Reported · Written up by our desk · Fund Industry

Novo Nordisk has struck a second licensing deal since presenting its long-term strategy to investors, which was met with a poor reception, according to MarketWatch.

MarketWatch reported that the company announced the licensing agreement on Tuesday.

← Newer storyNvidia authorizes record $150 billion share buyback increase Older story →Bitcoin is on track for a third straight monthly gain

More like this

ETFs & Funds“Funflation” captures rising hobby spending as prices keep climbing

ETFs & FundsShould an 80-year-old move due to dangerous stairs?

ETFs & FundsAI buildout faces $4.2 trillion funding gap, consulting firm says

ETFs & FundsKris Jenner delists Hidden Hills mansion from the market again

ETFs & FundsJPMorgan trading signals unit turns bullish on tech after a month

Sources

MarketWatchNovo Nordisk strikes second licensing deal since frosty capital-markets day

ETFs & Funds

Novo Nordisk signs second licensing deal after investors reacted coolly

More like this

Sources

Get the close, explained.